logowithText.png
Youth-HIV activist, Shamin Mohamed Jr., celebrates 15 years of LetsStopAIDS on World AIDS Day
November 29, 2019 07:00 ET | LetsStopAIDS
TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Canadian HIV-activist Shamin Mohamed Jr. founded LetsStopAIDS at 15 years old, a youth-driven HIV charity celebrating its 15th Anniversary on World AIDS...
2019_bc_export0481
bioLytical Laboratories Named B.C. Exporter of the Year
November 26, 2019 09:00 ET | bioLytical Laboratories Inc.
Award recognizes bioLytical as “the best of the best” for its achievements as an export company, and its contribution to the B.C. economy RICHMOND, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE)...
INSTI HIV-1/HIV-2 Antibody Test
INSTI now available for expanded point-of-care use in Canada
September 19, 2019 09:00 ET | bioLytical Laboratories Inc.
RICHMOND, British Columbia, Sept. 19, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in rapid diagnostic tests for infectious diseases, is pleased to announce that the INSTI HIV-1...
APLA Health Announce
APLA Health Announces Statewide Strategic Planning Meeting to Address Urgent Needs of People Aging with HIV
September 17, 2019 19:09 ET | APLA Health
Los Angeles, Sept. 17, 2019 (GLOBE NEWSWIRE) -- September 18 is National HIV/AIDS and Aging Awareness Day, and currently, the majority of people living with HIV are over the age of 50. To address...
Michael S. Gottlieb,
Michael S. Gottlieb, MD, Joins Medical Team at APLA Health-Olympic
February 08, 2019 12:58 ET | APLA Health
Los Angeles, Feb. 08, 2019 (GLOBE NEWSWIRE) -- APLA Health is excited to announce that Dr. Michael Gottlieb will join our medical team on February 11, 2019 at our new APLA Health – Olympic Health...
CocrystalPharmaInc.jpg
Cocrystal Pharma Provides Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
January 22, 2019 08:00 ET | Cocrystal Pharma, Inc.
- Hepatitis C program designed to develop ultra-short treatment for hepatitis C virus (HCV) consisting of CC-31244, an oral, potent, broad-spectrum non-nucleoside inhibitor, as a part of combination...
299982_GeoVaxLogo.jpg
GeoVax Observes National Gay Men’s HIV/AIDS Awareness Day
September 27, 2018 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Gay Men’s HIV/AIDS...
Conservative Government Missing on Endorsement of Global and Domestic Strategy to End AIDS
October 09, 2015 15:03 ET | B.C. Centre for Excellence in HIV/AIDS..
VANCOUVER, Oct. 9, 2015 (GLOBE NEWSWIRE) -- In response to a letter from the Director of the BC Centre for Excellence in HIV/AIDS (BC-CfE) Dr. Julio Montaner, all federal political parties - except...
Brazil Redoubles Efforts Against HIV and AIDS; Signs Letter of Intent with BC-CfE at the 2015 IAS Conference
July 22, 2015 15:52 ET | B.C. Centre for Excellence in HIV/AIDS..
VANCOUVER, British Columbia, July 22, 2015 (GLOBE NEWSWIRE) -- At the 2015 International AIDS Society (IAS) Conference, the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the Government of Brazil...
Doctors May Be Silenced for Warning of Health Risks, States Association of American Physicians and Surgeons (AAPS)
June 29, 2015 10:19 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., June 29, 2015 (GLOBE NEWSWIRE) -- After a distinguished 30-year career on the faculty of Harvard Medical School and the medical staff of Beth Israel Deaconess Medical Center (BIDMC) in...